Magnetic particle targeting is a new approach in cancer drug administration which aims to reduce side effects, increase healing rate and reduce treatment time. For this purpose a therapeutic agent is equipped with a magnetizable membrane and administered intravenously. A rare earth magnet can then be used to target cancerous tissue in proximity of the blood vessel.

This content is only available via PDF.
You do not currently have access to this content.